SCHEMBL4278697

SCHEMBL4278697

CNCn1c(=O)cc[nH]c1=S

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MPO P05164 9/20 0.34
TPO P07202 7/20 0.34
ALDH1A1 P00352 4/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
KCNH2 Q12809 1/20 0.34
KDM4E B2RXH2 2/20 0.32
MMP2 P08253 1/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
LPO P22079 1/20 0.31
PTGS1 P23219 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
OPRM1 P35372 1/20 0.31
TP53 P04637 1/20 0.31
DBH P09172 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1486017 0.81 TYMP (0.33) MPOTPOKCNH2MEN1KMT2A
SCHEMBL873253 0.81 OPRM1 (0.32) MPOALDH1A1POLBMAPTOPRM1
SCHEMBL8656963 0.79 ALDH1A1 (0.45) MPOALDH1A1MAPTKDM4EMMP2
SCHEMBL28328518 0.79
SCHEMBL41241 0.76 KDM1A (0.39) ALDH1A1KDM4EMEN1LMNALPO
SCHEMBL27672161 0.76 KDM1A (0.39) ALDH1A1KDM4EMEN1LMNALPO
SCHEMBL2227454 0.76 ALDH1A1 (0.39) ALDH1A1POLBMAPTMEN1KMT2A
SCHEMBL5792155 0.76 MMP2 (0.34) MPOTPOALDH1A1POLBMAPT
SCHEMBL11580947 0.76 ALDH1A1 (0.36) MPOTPOALDH1A1POLBMAPT
SCHEMBL29161647 0.75 OPRM1 (0.34) MPOALDH1A1POLBMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106170553-A Modified nucleic acid molecules and uses thereof 现代治疗公司 2016-11-30 CN claimed
WO-2024073709-A2 MODIFIED OLIGONUCLEOTIDES AND DOUBLE-STRANDED RNAS ALNYLAM PHARMACEUTICALS, INC. (US) 2024-04-04 WO disclosed
EP-3157573-A2 ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF Moderna Therapeutics, Inc. (US) 2017-04-26 EP disclosed
WO-2015196128-A2 ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF MODERNA THERAPEUTICS, INC. (US) 2015-12-23 WO disclosed
EP-2931319-A1 MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF Moderna Therapeutics, Inc. (US) 2015-10-21 EP disclosed
WO-2014093924-A1 MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF MODERNA THERAPEUTICS, INC. (US) 2014-06-19 WO disclosed
WO-2009126727-A1 RNA COMPOSITIONS FOR MODULATING IMMUNE RESPONSE ALNYLAM PHARMACEUTICALS, INC. (US) 2009-10-15 WO disclosed